First Time Loading...

Edap Tms SA
NASDAQ:EDAP

Watchlist Manager
Edap Tms SA Logo
Edap Tms SA
NASDAQ:EDAP
Watchlist
Price: 7.35 USD 3.52% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. [ Read More ]

The intrinsic value of one EDAP stock under the Base Case scenario is 5.23 USD. Compared to the current market price of 7.35 USD, Edap Tms SA is Overvalued by 29%.

Key Points:
EDAP Intrinsic Value
Base Case
5.23 USD
Overvaluation 29%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Edap Tms SA

Backtest EDAP Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling EDAP stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Edap Tms SA's business.

What risks and challenges
does Edap Tms SA face in the near future?

Summarize the latest earnings report
of Edap Tms SA.

Provide P/E
for Edap Tms SA and its competitors.

Financials

Balance Sheet Decomposition
Edap Tms SA

Current Assets 80.3m
Cash & Short-Term Investments 47.7m
Receivables 16.3m
Other Current Assets 16.2m
Non-Current Assets 13m
PP&E 8.1m
Intangibles 2.4m
Other Non-Current Assets 2.5m
Current Liabilities 25.9m
Accounts Payable 16.9m
Short-Term Debt 1.6m
Other Current Liabilities 7.4m
Non-Current Liabilities 7.2m
Long-Term Debt 2.4m
Other Non-Current Liabilities 4.8m
Efficiency

Earnings Waterfall
Edap Tms SA

Revenue
56.5m EUR
Cost of Revenue
-33.5m EUR
Gross Profit
23.1m EUR
Operating Expenses
-41m EUR
Operating Income
-17.9m EUR
Other Expenses
-3.4m EUR
Net Income
-21.3m EUR

Free Cash Flow Analysis
Edap Tms SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

EDAP Profitability Score
Profitability Due Diligence

Edap Tms SA's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Free Cash Flow
Positive Revenue Growth Forecast
30/100
Profitability
Score

Edap Tms SA's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

EDAP Solvency Score
Solvency Due Diligence

Edap Tms SA's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Short-Term Solvency
69/100
Solvency
Score

Edap Tms SA's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EDAP Price Targets Summary
Edap Tms SA

Wall Street analysts forecast EDAP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EDAP is 11.99 USD with a low forecast of 9.09 USD and a high forecast of 16.8 USD.

Lowest
Price Target
9.09 USD
24% Upside
Average
Price Target
11.99 USD
63% Upside
Highest
Price Target
16.8 USD
129% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

EDAP Price
Edap Tms SA

1M 1M
+16%
6M 6M
+5%
1Y 1Y
-34%
3Y 3Y
-24%
5Y 5Y
+145%
10Y 10Y
+157%
Annual Price Range
7.35
52w Low
4.15
52w High
11.92
Price Metrics
Average Annual Return 39.36%
Standard Deviation of Annual Returns 32.87%
Max Drawdown -68%
Shares Statistics
Market Capitalization 271.3m USD
Shares Outstanding 36 927 400
Percentage of Shares Shorted 0.19%

EDAP Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Edap Tms SA Logo
Edap Tms SA

Country

France

Industry

Health Care

Market Cap

271.3m USD

Dividend Yield

0%

Description

EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 227 full-time employees. The firm operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The firm invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The firm is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The firm is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.

Contact

AUVERGNE-RHONE-ALPES
Vaulx-en-Velin
4, rue du Dauphine, PA La Poudrette Lamartine
+33472153150.0
https://www.edap-tms.com/

IPO

1997-08-01

Employees

227

Officers

Executive Chairman
Mr. Marc Oczachowski
CEO & Director
Mr. Ryan Rhodes
Chief Financial Officer
Ken Mobeck
Chief Operating Officer
Mr. Carre Emmanuel
Global Chief Accounting Officer
Mr. Francois Dietsch
Investor Relations Officer & Secretary
Ms. Blandine Confort
Show More
President of EDAP TMS France
Mr. Frederic Pech
Show Less

See Also

Discover More
What is the Intrinsic Value of one EDAP stock?

The intrinsic value of one EDAP stock under the Base Case scenario is 5.23 USD.

Is EDAP stock undervalued or overvalued?

Compared to the current market price of 7.35 USD, Edap Tms SA is Overvalued by 29%.